Companies: 10,795·Total market cap: $144.5T
CeriBell, Inc.

CeriBell, Inc.

CBLLNASDAQHealthcare● Active
$18.14
$-0.11(-0.60%)
Market Cap$688280578
P/E Ratio
52W High$24.33
52W Low$10.85
Overview

CeriBell, Inc. (CBLL) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

cbll · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for CeriBell, Inc. (CBLL) measures how much investors pay for each dollar of the company's trailing earnings. CBLL's current PE ratio of N/A is calculated by dividing its stock price of $18.14 by its TTM earnings per share of -$1.60.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-1.15
Based on 6 analysts
EPS (TTM)
-$1.60
TTM · diluted EPS
PEG Ratio
-0.41
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CeriBell, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2022 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
CeriBell, Inc.
CeriBell, Inc.You
CBLL
$688MN/A-$1.60
Autolus Therapeutics plc
Autolus Therapeutics plc
AUTL
$389MN/A-$1.08
Butterfly Network, Inc.
Butterfly Network, Inc.
BFLY
$1.3BN/A-$0.31
Enhabit, Inc.
Enhabit, Inc.
EHAB
$707MN/A-$0.09
OrthoPediatrics Corp.
OrthoPediatrics Corp.
KIDS
$468MN/A-$1.69
Standard BioTools Inc.
Standard BioTools Inc.
LAB
$314MN/A-$0.20
Quantum-Si incorporated
Quantum-Si incorporated
QSI
$210MN/A-$0.51

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.46
2024-12-31
FY2024
$-3.39
2023-12-31
FY2023
$-1.26
2022-12-31
FY2022
$-1.59

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for CeriBell, Inc. (CBLL) measures how much investors pay for each dollar of the company's trailing earnings. CBLL's current PE ratio of N/A is calculated by dividing its stock price of $18.14 by its TTM earnings per share of -$1.60.

PE Ratio = Stock Price ÷ EPS (TTM)
= $18.14 ÷ -$1.60 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CBLL pe ratio · 6 questions

CBLL's current PE ratio is N/A as of 2026-06-08, based on a stock price of $18.14 and TTM EPS of -$1.60. Data sourced from Financial Modeling Prep via CBLL's SEC 10-K and 10-Q filings.

CBLL PE ratioWhat is CBLL PE ratioCurrent PE ratio of CBLLCBLL PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CeriBell, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08